bannerHON
img
HONnews
HONnews
img PATIENT / PARTICULIER img PROFESSIONNEL DE SANTE img WEBMESTRE img
img
 
img
HONcode sites
Khresmoi - new !
HONselect
News
Conferences
Images

Themes:
A B C D E F G H I
J K L M N O P Q
R S T U V W X Y Z
Browse archive:
2018: S A J J M A M F J
2017: D N O S

 
  Other news for:
Alzheimer Disease
Aspirin
Brain
 Resources from HONselect
Could Aspirin Help Keep Alzheimer's Away?

By Robert Preidt

THURSDAY, July 5, 2018 (HealthDay News) -- If new research in mice bears out in humans, that daily low-dose aspirin many people take to keep heart trouble at bay might also protect their brains against Alzheimer's.

Scientists report aspirin appeared to help clear out plaques of waste material called amyloid beta in the brain. Those plaques are a major sign of Alzheimer's disease.

"The results of our study identifies a possible new role for one of the most widely used, common, over-the-counter medications in the world," said senior study author Kalipada Pahan, chair of neurology at Rush Medical College, in Chicago.

Previous research has shown a link between aspirin and a reduced risk of Alzheimer's disease. In this study, the scientists gave low-dose aspirin for a month to genetically modified mice with a form of Alzheimer's disease.

The aspirin helped reduce amyloid plaques by boosting a protein called TFEB, a regulator of waste removal, and by stimulating lysosomes, a part of cells that help clear waste. But not all research in animals holds true for humans.

Still, "understanding how plaques are cleared is important to developing effective drugs that stop the progression of Alzheimer's disease," said Pahan.

"This research study adds another potential benefit to aspirin's already established uses for pain relief and for the treatment of cardiovascular diseases," he added in a Rush University news release.

"More research needs to be completed, but the findings of our study has major potential implications for the therapeutic use of aspirin in [Alzheimer's] and other dementia-related illnesses," Pahan said.

Alzheimer's disease affects up to one in 10 Americans aged 65 or older. Only a few drugs are approved for the treatment of Alzheimer's and those medications provide limited relief.

The study was published in the July issue of The Journal of Neuroscience.

More information

The U.S. National Institute on Aging has more about Alzheimer's disease.

SOURCE: Rush University, news release, July 2, 2018

Copyright © 2018 HealthDay. All rights reserved. URL:http://consumer.healthday.com/Article.asp?AID=735510

Resources from HONselect: HONselect is the HON's medical search engine. It retrieves scientific articles, images, conferences and web sites on the selected subject.
Aspirin
Brain
Therapeutics
Specialty Chemicals and Products
Alzheimer Disease
The list of medical terms above are retrieved automatically from the article.

Disclaimer: The text presented on this page is not a substitute for professional medical advice. It is for your information only and may not represent your true individual medical situation. Do not hesitate to consult your healthcare provider if you have any questions or concerns. Do not use this information to diagnose or treat a health problem or disease without consulting a qualified healthcare professional.
Be advised that HealthDay articles are derived from various sources and may not reflect your own country regulations. The Health On the Net Foundation does not endorse opinions, products, or services that may appear in HealthDay articles.


Home img About us img MediaCorner img HON newsletter img Site map img Ethical policies img Contact